MedPath

Efficacy of Unani Formulation in White Patches

Phase 2
Conditions
Health Condition 1: L80- Vitiligo
Registration Number
CTRI/2022/04/041571
Lead Sponsor
Rajiv Gandhi University Of Health Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects of Non-Segmental vitiligo (Acrofacial, focal and Generalized) of any sex

Subjects with Chronicity of less than 3 years

Subjects with less or equal to 2 percent Body surface Area (BSA)

Subjects fulfilling the Vitiligo Extent Tensity Index (VETI) score up to grade of tensity +3

Subjects who have not taken any treatment within the last 2 weeks

Exclusion Criteria

Patients aged less than18 years or greater than 60 years.

Patients with Segmental Vitiligo, Lip-Tip, Universal Vitiligo, Mucosal Vitiligo.

Patients with History of photosensitivity, photo exaggerated dermatoses and Connective Tissue Diseases.

Pregnant or Lactating Women.

Known cases of Cardiovascular, Endocrine, Pulmonary, Hepato-renal Dysfunction.

Known cases of Immunocompromised states like HIV AIDS, Malignancies

Patients not willing to attend treatment schedule regularly.

Patients suffering from cutaneous disorders like alopecia areata, halo nevus, Pityriasis alba, Malignant melanoma and Morphea.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath